Morgan, T. M., Pitts, T. E., Gross, T. S., Poliachik, S. L., Vessella, R. L., & Corey, E. (2008). RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased by Combination With Docetaxel and Zoledronic Acid.
استشهاد بنمط شيكاغوMorgan, Todd M., Tiffany E.M Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella, و Eva Corey. RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased By Combination With Docetaxel and Zoledronic Acid. 2008.
MLA استشهادMorgan, Todd M., et al. RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased By Combination With Docetaxel and Zoledronic Acid. 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.